Micro-x Ltd. · ASX:MX1
Micro-x — Shareholder Meeting (November 2021)
28 slides from Micro-x's shareholder meeting presentation, Nov 19, 2021
Slide 1: CEO Presentation – AGM 19 November 2021
For personal use only ACN 153 273 735 / ASX: MX1 C E O P R E S E N TAT I O N CLEAR VISION FOCUSED EXECUTION AGM - 19 November 2021 Peter Rowland Managing Director & CEO 2021 AGM – CEO Presentation
Slide 2: Video played at the meeting available on website
For personal use only The video played at the meeting can be viewed on the Company’s website 2021 AGM – CEO Presentation 1
Slide 3: Key Achievements for FY2021
KEY ACHIEVEMENTS FOR FY2021 Micro-X laid out the infrastructure for future growth across all four products For personal use only $3.6m of sales + establishment of ‘Argus’ bomb detection on time $8m non-dilutive funding with ASA multiple distributorships, non- and budget - strong police and under MRF
Slide 4: Our Strategy: How we Plan to Monetise Our First Mover Advantage
OUR STRATEGY How we Plan to Monetise Our ‘First Mover’ Advantage For personal use only OUR GOAL Successful first movers in breakthrough Early technology move quickly Commercial success becomes a barrier Four production lines commercial to entry for others leadsrship • common technology platforms • g
Slide 5: One Company – Four Businesses
O N E C O M PA N Y – F O U R B U S I N E S S E S Each unique product drives a new market-focused Business Unit For personal use only Mobile DR Cameras Checkpoints CT First Sales First Sales First Sales First Sales 2018 2022 2024 2026 Addressable Market Addressable Market Addressable Market Addressab
Slide 6: Mobile DR Business Unit
For personal use only MOBILE DR BUSINESS UNIT D r i v i n g P o i n t - o f - C a r e I m a g i n g F u r t h e r 5
Slide 7: Mobile DR – Controlling Our Destiny
MOBILE DR – CONTROLLING OUR DESTINY Building Commercial Capability – New Markets and Sales Channels For personal use only Strategy – lead by Charlie Hicks (30yr Radiology Industry expert) o Direct Sales executives – deep relationships in radiology and equipment sales o Independent Distributors and D
Slide 8: Mobile DR – Major Launch & Rebranding
MOBILE DR - MAJOR LAUNCH & REBRANDING RSNA – Largest Global Radiology Conference – 29 November 2021 For personal use only Showcasing Micro-X branding, Gen 2 product range & Tubes for Life warranty 2021 AGM – CEO Presentation 7
Slide 9: Mobile DR – Extended Portfolio
MOBILE DR – EXTENDED PORTFOLIO Point-of-Care Imaging - light weight and ultra-mobile for all applications For personal use only New Go to Market Strategy with updated branding & materials - greater customer focus and higher product margins Micro-X|Pico - Acute hospitals & temporary facilities Micro-
Slide 10: Mobile DR – Features Driving Sales
MOBILE DR – FEATURES DRIVING SALES Product features underpin strong differentiation over competition For personal use only Key selling features today Small size and weight gives ultra-mobility 25kg NEX Technology Comparison Extreme Reliability – ‘Tubes for Life’ Conventional x-ray tube and Micro-X W
Slide 11: X-Ray Camera Business Unit
For personal use only X-RAY CAMERA BUSINESS UNIT S a v i n g L i v e s b y S e e i n g D i f f e r e n t l y 10
Slide 12: X-Ray Camera – Revolutionising Bomb Disposal
X-RAY CAMERA-REVOLUTIONISING BOMB DISPOSAL Saving lives in the world’s most dangerous workplace For personal use only Global Problem – all IED Assessment with conventional x-ray requires placing a separate imaging detector Need to be ‘Over the Target’ with huge risk to human life 2021 AGM – CEO Pres
Slide 13: X-Ray Camera – 'Argus'
X-RAY CAMERA – ‘ARGUS’ Demonstrated capability driving strong customer interest For personal use only Key features are unparalleled World’s only bomb detector without a separate imaging detector Self-contained ‘camera’ carried by EOD robot for remote viewing High resolution image allows diagnosis to
Slide 14: X-Ray Camera – Commercial Execution
X-RAY CAMERA – COMMERCIAL EXECUTION 2022 will be a pivotal year with planned first sales For personal use only Q3-Q4 2021 Q2 2022 Trade shows – UK and USA Global Product Launch – US IABTI Conference, June 2022 Engagement on Military RFIs Argus Pre-production commences Argus prototype available First
Slide 15: X-Ray Camera – Preparing for 2022 Launch
X-RAY CAMERA – PREPARING FOR 2022 LAUNCH Pre-launch marketing to building awareness and sales pipeline For personal use only Target addressable market is $1.8B Police (urban counter-terrorism), Military (counter-IED), Border Forces (contraband) o Globally there are 5,500 counter-IED units* o 698 Pol
Slide 16: X-Ray Camera – Future Development
X-RAY CAMERA - FUTURE DEVELOPMENT Mine clearance and disposal for the ADF For personal use only Concept of Argus performing Route Clearance activities Argus detecting a buried mine 2021 AGM – CEO Presentation 15
Slide 17: Checkpoints Business Unit
For personal use only CHECKPOINTS BUSINESS UNIT A B e t t e r E x p e r i e n c e f o r T r a v e l l e r s 16
Slide 18: Checkpoints – Transforming Travel
CHECKPOINTS – TRANSFORMING TRAVEL Self service checkpoints – Speed and safety for future travellers For personal use only Customer driven concept to improve travel experience Passenger self-directed screening – integrates with passport scanning, photometric ID, body scan, baggage CT Automation will
Slide 19: Checkpoint – Core Technology Advantages
CHECKPOINT – CORE TECHNOLOGY ADVANTAGES Enabled by Cold Cathode X-ray – proven by UK Future Aviation Security contract For personal use only Technology enabler Micro-X CNT technology enables miniaturised high- resolution dual-energy CT scanners – size and speed Successful UK concept demonstration –
Slide 20: Checkpoints – Commercial by 2023
CHECKPOINTS – COMMERCIAL BY 2023 Funded by the only two Contracts with US Dept. of Homeland Security For personal use only Miniaturised CT – Baggage scanner Full Self-Service Portal Compelling value proposition for DHS TSA operates 2,200 x-ray lanes across 440 airports in the United States* TSA manp
Slide 21: Checkpoint – Strategy
CHECKPOINT –STRATEGY Micro-X is taking Leadership Role, Prime Contracting with our Collaborators For personal use only Developing Transformative Leading a Global Engaging with Regulators Actively Participating Core Technology Team of Innovators and Customers Industry Work Shops: Real-time Mm- Automa
Slide 22: CT Business Unit
For personal use only CT BUSINESS UNIT C T s o S m a l l i t c a n F l y 21
Slide 23: CT – A New Standard of Care for Stroke
CT - A NEW STANDARD OF CARE FOR STROKE Taking stroke diagnosis from the hospital to the ambulance For personal use only Saving lives for millions of stroke victims – the Golden Hour Nearly 2 million brain cells die per minute during an ischemic stroke Three out of four strokes are clots – diagnostic
Slide 24: CT – Stroke Diagnosis Using Micro-X CNT
CT –STROKE DIAGNOSIS USING MICRO-X CNT Enabling highly mobile and miniature X-Ray imaging for stroke diagnosis For personal use only Current technology – large and heavy CNT delivers perfect solution – small and mobile A conventional CT gantry spins at 200rpm Mobile CT with 29 mini X-ray tubes and n
Slide 25: CT – Commercial Product in Years
CT – COMMERCIAL PRODUCT IN 4 YEARS A$8m Australian Government MRFF programme – Stroke Golden Hour For personal use only $8m funding from Australian Stroke Alliance Robust CT imager with no moving parts – small enough and affordable to be fitted to every ambulance (land & air) Micro-X CT Scanner expe
Slide 26: Summary – Four Dedicated Businesses
SUMMARY - FOUR DEDICATED BUSINESSES Focused resourcing and accountability to maximise growth For personal use only Mobile DR - Healthcare X-Ray Camera - Security • Medical, Military and Veterinary • Total addressable market of $1.8B • Customers – hospitals, military, vets • Customers - defence and c
Slide 27: Important Notice
IMPORTANT NOTICE For personal use only S C O P E & L I M I T A T I O N S This Presentation has been prepared by Micro-X Limited (Micro-X or the Company) (ASX.MX1). The Presentation is a summary only and does not contain all the information about the Company’s assets and liabilities, financial positi
Slide 28: Thank You
ACN 153 273 735 / ASX: MX1 For personal use only THANK YOU 2 7